title: Surgery during etanercept therapy in patients with rheumatoid arthritis: is it time to follow patient preferences?
authors.forename: Salvatore
authors.initials: S
authors.lastname: Corrao
authors.forename: Giovanni
authors.initials: G
authors.lastname: Pistone
authors.forename: Sabrina
authors.initials: S
authors.lastname: Arnone
authors.forename: Luigi
authors.initials: L
authors.lastname: Calvo
authors.forename: Rosario
authors.initials: R
authors.lastname: Scaglione
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Licata
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000601:surgery*; D000075202:Contraindications; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage* / Q000009:adverse effects; D007558:Italy; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D011183:Postoperative Complications / Q000139:chemically induced / Q000517:prevention & control; D011788:Quality of Life; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage*; D013514:Surgical Procedures, Operative; D014945:Wound Healing
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept